Every year I make stem cell and regenerative medicine predictions. Looking at my predictions for 2023, they reflect a wild year but in many ways a good one overall. Below I have graded my 2023 predictions. Overall, my crystal ball gave solid results. Some of the predictions have been condensed to keep things concise, but you …
2023 stem cell predictions grades reflect wild year for regenerative medicine Read More »
Retraction Watch has been a great resource for those of us who have been following research misconduct. They widely cover and conduct research on retractions, corrections, and other developments in this space. Unfortunately, there’s been plenty to write about even just within the stem cell and cell therapy arena, which is my primary interest. Think …
There is still plenty of reason to worry about unproven stem cells being marketed in the U.S. and elsewhere around the world. I’ll start with a new item here in the U.S. on a firm called MD Stem Cells and end with a newly published paper about how things are going in Poland on this …
Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates Read More »
There has been a big jump in paper retractions in science over the last 20 years. What’s going on? How do the trends in the stem cell field compare to other fields like cancer research and more broadly? Is AI going to change the dynamic between those engaging in misconduct and those who are looking for misconduct …
Trends in retractions as AI arms race on misconduct looms Read More »
There have been rare instances like with scientist James Wilson where researchers were involved in what I would call major misconduct but somehow managed to bounce back. In a sense, they were given second chances in part by regulators but also by other scientists or supporters. However, after extraordinary misconduct, especially contributing to the death …
2nd chances after big misconduct? He Jiankui, James Wilson, others Read More »
I am in the unique position of being a stem cell scientist who has no commercial interest in selling therapies so I can be impartial on giving patients and consumers guidance. In today’s post I give an overview of stem cell therapy and provide an expert, unbiased guide to navigating this area. This post is …
Updated patients guide to stem cell therapy for 2024 Read More »
Here are some recommended stem cell and other reads for the week ranging from COVID developments to prosecutors finally catching up with a stem cell surgeon who had many patients die to a list of interesting pubs. Because Trump now has COVID, I wondered on Friday if he might consider trying unproven stem cells or …
Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more Read More »
Bulls-eye! Here are some stem cell weekend reads including both interesting new papers & news headlines. Of course, this week also had stem cell awareness day and I wrote about 10 key issues for the field for the coming 10 years! Weekend reads Papers Chromatin and Single-Cell RNA-Seq Profiling Reveal Dynamic Signaling and Metabolic Transitions during …
Below are the 2016 stem cell predictions I made last year and their status now color-coded near year’s end. Green is right, orange is mixed bag, and red is flat out wrong. Overall, I did better than most past years with only having entirely blown it on four. Stay tuned later this week for my 2017 predictions, …
Grading my stem cell predictions for 2016: how’d I do? Read More »
Each December I make stem cell predictions for the coming year and I did that for 2016 where I made 20 predictions. At around mid year I do a checkup on how my predictions are doing halfway and that is the purpose of this post. Below are my predictions that I made in 2015 for stem …
Stem cell checkup: how are my 2016 predictions doing half way? Read More »